ePT--the Electronic Newsletter of Pharmaceutical Technology
Baltimore, MD (Sept. 10)-Researchers at Johns Hopkins University have devised a new controlled-delivery system that applies an electrical pulse to release drug molecules, nanoparticles, biopolymers such as peptides and proteins, and protein assemblies such as viruses from thin fabricated gold electrodes. Developers hope the technique will allow biocompatible implantable chips for precisely dispensing small amounts of drug into the body.
Baltimore, MD (Sept. 10)-Researchers at Johns Hopkins University (JHU, www.jhu.edu) have devised a new controlled-delivery system that applies an electrical pulse to release drug molecules, nanoparticles, biopolymers such as peptides and proteins, and protein assemblies such as viruses from thin fabricated gold electrodes. Led by Peter C. Searson, professor of material science and engineering at JHU, the scientists hope the technique someday will develop into a biocompatible implantable chip for precise and controlled dispensing of small amounts of drug into the body.
The researchers constructed long chains of hydrocarbon molecules. One end of the chain was anchored by a gold?sulfur bond to specially designed gold electrodes, each the width of a single human hair. The biomolecule to be released was attached to the other end. When a brief electrical pulse was sent through wires attached to each electrode, it broke the bond between the sulfur atoms and the gold platform, causing the tethered molecule to be released at a precise time.
The technology reportedly has several advantages over similar delivery techniques. “Because our molecules are attached to a surface, we can work with much smaller concentrations. We’ve also shown that our system is reusable. After a group of molecules is released, you can easily attach new molecules to an electrode and use it again,” says Searson.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.